This compound is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its unique structure, featuring a trifluoromethyl group and an amino alcohol moiety, makes it valuable in the development of drugs targeting neurological disorders, such as antidepressants and antipsychotics. Additionally, it is employed in the creation of small molecule inhibitors for enzymes and receptors, contributing to the treatment of inflammatory and autoimmune diseases. The chiral nature of the compound also allows for its use in asymmetric synthesis, enhancing the efficiency and selectivity of drug manufacturing processes.